Hot and cold tumors: Immunological features and the therapeutic strategies DOI Creative Commons
Lianjie Wang, Hui Geng, Yujie Liu

и другие.

MedComm, Год журнала: 2023, Номер 4(5)

Опубликована: Авг. 26, 2023

Abstract The “hotness” or “coldness” of the tumors are determined by information cancer cells themselves, tumor immune characteristics, microenvironment, and signaling mechanisms, which key factors affecting patients’ clinical efficacy. switch mechanism its corresponding pathological characteristics treatment strategies frontier hot spot treatment. How to distinguish effectively clarify causes, microenvironment state, very important for response efficacy treatments. Starting from concept cold tumor, this review systematically summarized molecular influencing factors, therapeutic “hot tumors,” analyzed immunophenotypes, pathways, markers that contribute tumors” in details. Different “cold based on were with drug targets proteins tumors.” Furthermore, combines different traditional medicine modern medicine, provide a basis guidance decision‐making

Язык: Английский

Hepatocellular carcinoma DOI Open Access
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva

и другие.

Nature Reviews Disease Primers, Год журнала: 2021, Номер 7(1)

Опубликована: Янв. 21, 2021

Язык: Английский

Процитировано

4472

Tertiary lymphoid structures in the era of cancer immunotherapy DOI
Catherine Sautès‐Fridman, Florent Petitprez, Julien Caldéraro

и другие.

Nature reviews. Cancer, Год журнала: 2019, Номер 19(6), С. 307 - 325

Опубликована: Май 15, 2019

Язык: Английский

Процитировано

1303

Immunotherapies for hepatocellular carcinoma DOI
Josep M. Llovet, Florian Castet, Mathias Heikenwälder

и другие.

Nature Reviews Clinical Oncology, Год журнала: 2021, Номер 19(3), С. 151 - 172

Опубликована: Ноя. 11, 2021

Язык: Английский

Процитировано

1170

Tertiary lymphoid structures in cancer DOI
Ton N. Schumacher, Daniela S. Thommen

Science, Год журнала: 2022, Номер 375(6576)

Опубликована: Янв. 6, 2022

Ectopic lymphoid aggregates, termed tertiary structures (TLSs), are formed in numerous cancer types, and, with few exceptions, their presence is associated superior prognosis and response to immunotherapy. In spite of presumed importance, the triggers that lead TLS formation tissue contribution these intratumoral immune responses remain incompletely understood. Here, we discuss present knowledge on TLSs cancer, focusing (i) drivers formation, (ii) function antitumor response, (iii) potential as therapeutic targets human cancers.

Язык: Английский

Процитировано

649

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer DOI Creative Commons
Maxime Meylan, Florent Petitprez, Étienne Becht

и другие.

Immunity, Год журнала: 2022, Номер 55(3), С. 527 - 541.e5

Опубликована: Фев. 28, 2022

Язык: Английский

Процитировано

441

Molecular and histological correlations in liver cancer DOI Creative Commons
Julien Caldéraro, Marianne Ziol, Valérie Paradis

и другие.

Journal of Hepatology, Год журнала: 2019, Номер 71(3), С. 616 - 630

Опубликована: Июнь 10, 2019

Язык: Английский

Процитировано

435

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome DOI
Wolf H. Fridman, Maxime Meylan, Florent Petitprez

и другие.

Nature Reviews Clinical Oncology, Год журнала: 2022, Номер 19(7), С. 441 - 457

Опубликована: Апрель 1, 2022

Язык: Английский

Процитировано

398

Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications DOI
Terence K. Lee, Xin‐Yuan Guan, Stephanie Ma

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2021, Номер 19(1), С. 26 - 44

Опубликована: Сен. 9, 2021

Язык: Английский

Процитировано

320

Intratumoral heterogeneity and clonal evolution in liver cancer DOI Creative Commons
Bojan Losic, Amanda J. Craig, Carlos Villacorta-Martín

и другие.

Nature Communications, Год журнала: 2020, Номер 11(1)

Опубликована: Янв. 15, 2020

Abstract Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally immune and treatment mediated. We integrate RNA-seq, DNA sequencing, TCR-seq SNP array data across multiple regions liver cancer specimens to map spatio-temporal interactions between cells. investigate how these reflect intra-tumor heterogeneity (ITH) by correlating regional neo-epitope viral antigen burden with the adaptive response. Regional expression passenger mutations dominantly recruits responses as opposed hepatitis B virus cancer-testis antigens. detect clonal expansion system in distant same tumor. An ITH-based gene signature improves single-biopsy patient survival predictions an survey 38,553 single cells 7 2 patients further reveals cancer. These quantify transcriptomic ITH components HCC interact during evolution.

Язык: Английский

Процитировано

298

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma DOI Creative Commons
Yiming Lu, Aiqing Yang,

Cheng Quan

и другие.

Nature Communications, Год журнала: 2022, Номер 13(1)

Опубликована: Авг. 6, 2022

Abstract Hepatocellular carcinoma (HCC) represents a paradigm of the relation between tumor microenvironment (TME) and development. Here, we generate single-cell atlas multicellular ecosystem HCC from four tissue sites. We show enrichment central memory T cells (T CM ) in early tertiary lymphoid structures (E-TLSs) assess relationships chronic HBV/HCV infection cell infiltration exhaustion. find MMP9 + macrophages to be terminally differentiated tumor-associated (TAMs) PPARγ pivotal transcription factor driving their differentiation. also characterize heterogeneous subpopulations malignant hepatocytes multifaceted functions shaping immune HCC. Finally, identify seven microenvironment-based subtypes that can predict prognosis patients. Collectively, this large-scale deepens our understanding microenvironment, which might facilitate development new therapy strategies for malignancy.

Язык: Английский

Процитировано

249